Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07005349

THUMB: Multi-centre Cluster Trial for Caesarean Section Haemorrhage

The quality improvement project evaluating the delivery of a perioperative care complex intervention to improve haemorrhage-related outcomes in patients undergoing caesarean section. The objectives of the current study will be:

1. To evaluate whether implementation of the 'Rule of THUMB' perioperative complex intervention increases risk assessment, diagnosis and compliance with proven interventions for haemorrhage during and after caesarean section. 2. To understand the influence of contextual and socio-dynamic factors on how the trial results were achieved and how the intervention mechanisms did, or did not, work in practice (the process evaluation). The findings from this study will be used subsequently to modify and improve the quality improvement intervention, so that it can be delivered at scale across Africa and assess its impact on haemorrhage during and after caesarean section in the future.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Mowbray Maternity Hospital

Cape Town, South Africa

Location status: Recruiting

Location contact

Margot Flint, PhD

CONTACT

[email protected]

0721222111

About this study

The study involves a complex intervention to improve maternal outcomes for patients undergoing caesarean section based on early diagnosis of haemorrhage during and after surgery coupled to early treatment through first-responder protocolised treatment using a care bundle of five elements called the rule of THUMB. The intervention is essentially a quality improvement programme aimed at delivering better care, care that is already known to be effective in delivering better patient outcomes. The intervention comprises two mandatory risk assessments (preoperatively in theatre and postoperatively prior to discharge from the recovery area) which are linked to hospital-specific responses. Assessments for bleeding will occur intraoperatively (through direct vision, haemodynamic changes and/or measurement of blood loss) and postoperatively (with the use of the rapid assessment tool). If bleeding is diagnosed at any point, the THUMB checklist will be used to activate bundled care. On discharge from recovery, high-risk patients will be scheduled to receive a postoperative ward visit within four hours, when a further assessment for bleeding will occur. Staff at each hospital will collect data for the two-week usual care (control) phase describing usual perioperative care. This will be followed by a period of co-design and training (2-6 weeks, as required), and then implementation of the intervention phase for a further two weeks at each hospital. The initial intervention will be modified in accordance with data collected during the usual care phase, in conjunction with local stakeholders. Further intervention refinement will occur after each period of data recruitment and analysis. Two intervention cycles will occur. The intervention is essentially a quality improvement programme aimed at delivering better care, care that is already known to be effective in delivering better patient outcomes. The intervention aims to improve compliance with recommended care for prevention and treatment of haemorrhage during and after caesarean section by creating a bundle of care that is delivered simultaneously (not sequentially) by first responders. It includes two mandated risk assessments before and after surgery, and implementation of the THUMB care bundle either in response to bleeding intraoperatively or in recovery or the ward through the rapid assessment tool.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any patient who requires a caesarean section in participating countries with hospitals that routinely perform caesarean section.

Exclusion criteria

  • Patients who opt out of the trial will be excluded.

Treatment and study plan

Quality improvement program

Other

The intervention comprises two mandatory risk assessments (preoperatively in theatre and postoperatively prior to discharge from the recovery area) which are linked to hospital-specific responses. Assessments for bleeding will occur intraoperatively (through direct vision, haemodynamic changes and/or measurement of blood loss) and postoperatively (with the use of the rapid assessment tool). If bleeding is diagnosed at any point, the THUMB checklist will be used to activate bundled care. On discharge from recovery, high-risk patients will be scheduled to receive a postoperative ward visit within four hours, when a further assessment for bleeding will occur.

Primary outcomes

  1. Patient assessed as high-risk for postpartum haemorrhage

    Time frame: 6 months

    To evaluate the effect of the trial intervention on identification of high-risk patients

  2. Administration of uterotonics intra- or postoperatively

    Time frame: 6 months

    To evaluate the effect of the trial intervention on administration of uterotonics

  3. Administration of tranexamic acid intra- or postoperatively

    Time frame: 6 months

    To evaluate the effect of the trial intervention on administration of tranexamic acid

  4. Uterine massage intra- or postoperatively after delivery of the baby

    Time frame: 6 months

    To evaluate the effect of the trial intervention on uterine massage

  5. A postoperative clinician visit within four hours of discharge to the ward

    Time frame: 6 months

    To evaluate the effect of the trial intervention on clinician ward visit postoperatively

Secondary outcomes

  1. Diagnosis of postpartum haemorrhage

    Time frame: 6 months

    To evaluate the effect of the trial intervention on a diagnosis of postpartum haemorrhage

  2. 30 day in-hospital mortality

    Time frame: 6 months

    To evaluate the effect of the trial intervention on 30 day in-hospital mortality

  3. Repeat laparotomy for suspected haemorrhage

    Time frame: 6 months

    To evaluate the effect of the trial intervention on repeat laparotomy for suspected haemorrhage

  4. Duration of hospital stay

    Time frame: 6 months

    To evaluate the effect of the trial intervention on duration of hospital stay

  5. Referral to higher level of care for further management of bleeding/resuscitation

    Time frame: 6 months

    To evaluate the effect of the trial intervention on referral to higher level of care for further management of bleeding/resuscitation

Study contacts

Contact information is provided by the study sponsor or research team.

BRUCE BICCARD, PhD

CONTACT

[email protected]

00274045015

MARGOT FLINT, PhD

CONTACT

[email protected]

00274045001

Sponsors and collaborators

Lead sponsor

Bruce Biccard

Other

Registry information

Official study title

Rule of THUMB: A Multi-centre Cluster Trial Evaluating the Implementation of a Perioperative Care Complex Intervention to Improve Outcomes From Haemorrhage During and After Caesarean Section in African Hospitals

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 5, 2025
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.